🇺🇸 FDA
Pipeline program

VIR-3434

VIR-3434-1002

Phase 1 mab completed

Quick answer

VIR-3434 for Chronic Hepatitis B is a Phase 1 program (mab) at Vir Biotechnology with 1 ClinicalTrials.gov record(s).

Program details

Company
Vir Biotechnology
Indication
Chronic Hepatitis B
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials